Ubs Asset Management Americas Inc Revolution Medicines, Inc. Transaction History

Ubs Asset Management Americas Inc

$477 Billion
Q2 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 500,697 shares of RVMD stock, worth $23.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

500,697

Previous 300,196 66.79%

Holding current value

$23.3 Million

Previous $10.6 Million 73.54%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$31.13 - $41.98 $6.24 Million - $8.42 Million	200,501 Added 66.79%	500,697 $18.4 Million
Q1 2025 May 19, 2025	BUY	$35.36 - $44.42 $1.32 Million - $1.66 Million	37,345 Added 14.21%	300,196 $10.6 Million
Q4 2024 Feb 14, 2025	BUY	$42.97 - $60.6 $2.01 Million - $2.84 Million	46,825 Added 21.68%	262,851 $11.5 Million
Q3 2024 Nov 14, 2024	SELL	$36.92 - $47.94 $938,543 - $1.22 Million	-25,421 Reduced 10.53%	216,026 $9.79 Million
Q2 2024 Aug 13, 2024	BUY	$30.14 - $40.68 $3.26 Million - $4.4 Million	108,273 Added 81.3%	241,447 $9.37 Million
Q4 2023 Feb 14, 2024	BUY	$18.35 - $34.12 $530,975 - $987,296	28,936 Added 27.76%	133,174 $3.82 Million
Q3 2023 Nov 13, 2023	BUY	$25.17 - $35.05 $350,190 - $487,650	13,913 Added 15.4%	104,238 $2.89 Million
Q1 2023 May 15, 2023	BUY	$20.76 - $30.09 $569,322 - $825,188	27,424 Added 43.6%	90,325 $1.96 Million
Q4 2022 Feb 14, 2023	BUY	$17.68 - $25.53 $334,328 - $482,772	18,910 Added 42.99%	62,901 $1.5 Million
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $8,049 - $11,986	461 Added 1.06%	43,991 $867,000
Q2 2022 Aug 12, 2022	SELL	$14.54 - $27.17 $203,676 - $380,597	-14,008 Reduced 24.35%	43,530 $848,000
Q1 2022 May 16, 2022	BUY	$17.31 - $26.4 $289,492 - $441,513	16,724 Added 40.98%	57,538 $1.47 Million
Q4 2021 Feb 14, 2022	BUY	$24.35 - $33.7 $48,261 - $66,793	1,982 Added 5.1%	40,814 $1.03 Million
Q3 2021 Nov 15, 2021	BUY	$23.95 - $33.41 $8,909 - $12,428	372 Added 0.97%	38,832 $1.07 Million
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $468,640 - $766,630	16,160 Added 72.47%	38,460 $1.22 Million
Q1 2021 May 14, 2021	SELL	$37.21 - $54.43 $94,104 - $137,653	-2,529 Reduced 10.19%	22,300 $1.02 Million
Q4 2020 Mar 01, 2021	BUY	$30.19 - $45.49 $535,238 - $806,492	17,729 Added 249.7%	24,829 $982,000
Q3 2020 Nov 13, 2020	BUY	$22.61 - $34.8 $160,531 - $247,079	7,100 New	7,100 $247,000

Others Institutions Holding RVMD

# of Institutions

333

Shares Held

195M

Call Options Held

908K

Put Options Held

723K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $4.08B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Revolution Medicines, Inc. Transaction History